Home › Funds › T. Rowe Price Associates › CVS
T. Rowe Price Associates position in CVS
CVS HEALTH CORP · Consumer Staples
Latest position (Q2 2026)24.20M sh
Reported value held$2.50M
Portfolio Weight0.26%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 10.62M | $901.61M | New |
| Q4 2021 | 10.49M | $1.08B | Reduce |
| Q1 2022 | 10.20M | $1.03B | Reduce |
| Q2 2022 | 9.81M | $909.11M | Reduce |
| Q3 2022 | 9.61M | $916.43M | Reduce |
| Q4 2022 | 10.62M | $989.26K | Add |
| Q1 2023 | 8.91M | $661.86K | Reduce |
| Q2 2023 | 9.76M | $675.00K | Add |
| Q3 2023 | 10.71M | $747.57K | Add |
| Q4 2023 | 10.69M | $843.75K | Hold |
| Q1 2024 | 10.70M | $853.36K | Hold |
| Q2 2024 | 10.24M | $604.56K | Reduce |
| Q3 2024 | 11.71M | $736.08K | Add |
| Q4 2024 | 13.37M | $600.02K | Add |
| Q1 2025 | 15.31M | $1.04M | Add |
| Q2 2025 | 16.61M | $1.15M | Add |
| Q3 2025 | 17.40M | $1.31M | Add |
| Q4 2025 | 16.44M | $1.30M | Reduce |
| Q1 2026 | 23.78M | $1.71M | Add |
| Q2 2026 | 24.20M | $2.50M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CVS
- BlackRock Inc 123.22M sh · $12.75B · Q2 2026
- Vanguard Group 120.71M sh · $9.58B · Q4 2025
- Capital World Investors 74.95M sh · $7.75B · Q2 2026
- Dodge & Cox 50.01M sh · $5.17B · Q2 2026
- Wellington Management Group 33.80M sh · $3.50B · Q2 2026
- Geode Capital Management 29.90M sh · $3.08B · Q2 2026
- Fidelity Management & Research (FMR) 28.92M sh · $2.99B · Q2 2026
- Capital Research Global Investors 24.33M sh · $2.52B · Q2 2026
- Bank of America Corp 23.19M sh · $2.40B · Q2 2026
- Invesco Ltd 20.60M sh · $2.13B · Q2 2026
- Morgan Stanley 18.61M sh · $1.92B · Q2 2026
- Norges Bank Investment Management 18.04M sh · $1.87B · Q2 2026